About
The LifeFactFuture (LFF) project combines world class-excellence of Finnish life science companies, technology companies and academic researchers. It seeks to enhance advanced pharmaceutical and life science manufacturing in Finland.
The LFF consortium includes research teams at the University of Turku and the University of Helsinki, as well as some of Finland’s leading life science manufacturers, data and technology companies. The goal of the project collaboration is to speed up the introduction of digital solutions and more efficient utilization of data and to make Finland the most attractive place in the world for investments in data-driven life science manufacturing.
Current global vendors for pharmaceutical manufacturing are not able to provide the critical future data capabilities already identified by the sector in Finland. The data-driven capabilities offered by life science manufacturing vendors are assessed as less mature than similar solutions for other manufacturing sectors such as the automotive industry.
If Finland becomes the lighthouse for exploiting new data-driven capabilities in advanced life sciences manufacturing, new billion-euro export opportunities are on the horizon. The export potential is considerable within the life science sector itself as well as within technology industry companies supplying the life science sector with data-driven capabilities.
LFF is designed to fulfill the following objectives:
- World-class, interdisciplinary research published in high-level journals.
- Map the transformative potential of data-driven capabilities in pharmaceutical manufacturing.
- Facilitate the design and adoption of regulatory practices in favor of agile/adaptive manufacturing.
- Support the development of technology Proofs of Concept advancing data-driven life science manufacturing.
- Progress made in developing sustainable business competencies in digital production environment.
The consortium is led by the Finland Futures Research Centre, University of Turku and
funded by Business Finland during 2024–2026.